Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial.
Ohtani Y, Tani H, Nomoto-Takahashi K, Yatomi T, Yonezawa K, Tomiyama S, Nagai N, Kusudo K, Honda S, Moriyama S, Nakajima S, Yamada T, Morisaki H, Iwabuchi Y, Jinzaki M, Yoshimura K, Eiro T, Tsugawa S, Ichijo S, Fujimoto Y, Miyazaki T, Takahashi T, Uchida H.
Ohtani Y, et al. Among authors: iwabuchi y.
Psychiatry Clin Neurosci. 2024 Dec;78(12):765-775. doi: 10.1111/pcn.13734. Epub 2024 Aug 30.
Psychiatry Clin Neurosci. 2024.
PMID: 39210712
Free PMC article.
Clinical Trial.